Trial Profile
The role of DNA methylation in resistance to sunitinib in renal cell cancer
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 23 Apr 2013
Price :
$35
*
At a glance
- Drugs Sunitinib (Primary)
- Indications Renal cell carcinoma
- Focus Therapeutic Use
- 23 Apr 2013 New trial record